EGFR and non-small cell lung carcinoma: Various studies have identified specific EV biomarkers such as EGFR, circSATB2, and miRNAs, and demonstrated their therapeutic implications and potential for early detection, and prognosis of NSCLC (138, 139, 143, 150–154).